Pharmaceutical Grade 99% Calcipotriol monohydrate CAS:147657-22-5 for EP Standard

Calcipotriol monohydrate, with the CAS number 147657-22-5, is a synthetic derivative of vitamin D3. It is primarily utilized in dermatology for the treatment of psoriasis, a chronic skin condition characterized by rapid skin cell proliferation leading to thickened, scaling plaques. Calcipotriol is valued for its ability to modulate cell differentiation and proliferation, contributing effectively to the normalization of excessive skin cell production seen in psoriasis.

Description:
Calcipotriol monohydrate is presented as a white or off-white crystalline powder. It is soluble in organic solvents but only slightly soluble in water, which reflects its lipophilic nature. Being an analog of vitamin D3, it shares structural similarities with natural vitamins involved in calcium regulation and skin cell health. Its chemical structure enables specific binding to the vitamin D receptor (VDR), which plays a crucial role in various physiological processes, including the modulation of immune responses and cellular development.

Mechanism of Action:
The therapeutic effects of calcipotriol are closely linked to its interaction with the vitamin D receptor (VDR). When calcipotriol binds to VDR, it forms a complex that enters the cell nucleus and attaches to specific DNA sequences, modulating the transcription of genes involved in cell proliferation and differentiation. This results in the correction of abnormal keratinocyte activity observed in psoriatic lesions.
Furthermore, calcipotriol inhibits the overproduction of skin cells and reduces inflammation by affecting cytokine expression in T-cells and keratinocytes. This mechanism helps in managing the classical symptoms of psoriasis such as redness, thickness, and scaling of the skin.

Usage:
Calcipotriol is predominantly used in the topical treatment of plaque psoriasis of the skin and scalp. It is often available in formulations such as creams, ointments, gels, and certain scalp solutions, providing flexibility based on the location and extent of the psoriatic involvement. The treatment regimens usually include once or twice daily application to the affected areas.

Combining calcipotriol with other therapeutic agents, such as corticosteroids or phototherapy, is a common practice to enhance treatment efficacy and patient outcomes. This combinatory approach can also help in reducing the potential side effects associated with long-term usage of corticosteroids alone.

Patients are generally advised about proper application techniques to enhance absorption and efficacy. This includes applying a thin layer of the preparation to affected areas and washing hands after application to prevent inadvertent spread to other body parts with healthy skin.

Chemical Classification:
Calcipotriol belongs to the class of secosteroids, a subclass of steroids that are characterized by a 'broken' ring structure. It is a non-steroidal compound derived from vitamin D3 which provides therapeutic benefits without some of the side effects commonly associated with corticosteroids.

Being a vitamin D analog, calcipotriol's chemical classification is further refined under the analogs utilized in dermatological conditions due to their immunomodulatory and cell proliferation regulating properties. Its development was aimed at minimizing calcium metabolism alteration—a side effect commonly seen with other vitamin D derivatives—while maximizing dermal efficacy.

Additional Considerations:
Calcipotriol is generally well-tolerated, but like all medications, potential side effects can occur. These may include mild irritation at the site of application, and in rare cases, photosensitivity. Patients are usually advised to avoid excessive sunlight exposure and use appropriate sun protection measures during treatment.

Another significant aspect to note is the importance of adhering to prescribed doses, as vitamin D analogs have the potential to alter systemic calcium levels when used excessively.

For optimized benefits, patient compliance to treatment protocols and regular follow-up with healthcare providers to monitor response and adjust therapy as needed is crucial.
Research into calcipotriol's use is ongoing, with studies exploring its benefits in combination with newer systemic treatments, providing hope for enhanced management options for individuals suffering from psoriasis.

In summary, calcipotriol monohydrate stands as a cornerstone treatment for localized psoriasis due to its targeted action on VDR, bringing relief by restoring normal keratinocyte function and easing inflammatory responses. Its design as a vitamin D analog ensures that patients receive focused dermatologic therapy with a minimized risk of systemic side effects, emphasizing its role as a vital tool in the dermatologic arsenal against psoriasis.